Logo
LUMI PN EYES 1×1.5ml

LUMI PN EYES 1×1.5ml

LUMI-PN

Injectable skin booster
  • Marketed by multiple UK and EU aesthetic suppliers as a professional Use polynucleotide skin booster for the under Eye/periocular area.
  • Produced under medical Aesthetic manufacturing quality systems; practitioners should verify CE/UKCA marking and device classification information directly on packaging and in technical documentation.
  • Use restricted to trained healthcare/aesthetic professionals in compliance with local regulations governing injectable aesthetic devices and skin boosters.
Polynucleotide (PDRN) under-eye/periocular skin booster

Description

LUMI-PN EYES 1×1.5ml is an innovative polynucleotide (PDRN) skin booster specifically formulated for the delicate under-eye and periocular region. Containing ultra-pure polydeoxyribonucleotide at a concentration of 20 mg/ml, each 1.5 ml pre-filled syringe delivers a total of 30 mg PDRN. The treatment is designed to promote skin tissue regeneration, stimulate new collagen synthesis, and improve microcirculation and dermal quality, targeting dark circles, fine lines, dullness and early signs of ageing around the eyes. Rather than acting as a volumising filler, LUMI-PN EYES works via regenerative, biostimulatory mechanisms to enhance hydration, elasticity, smoothness and radiance, resulting in brighter, more even-toned and refreshed-looking under-eyes when used as part of a professional aesthetic protocol.

Bnefits

  • High-purity polynucleotide (PDRN) skin booster tailored specifically for under-eye and periocular rejuvenation.
  • Delivers 30 mg of ultra-pure PDRN in a 1.5 ml syringe at 20 mg/ml concentration for potent regenerative activity.
  • Promotes skin tissue regeneration and supports fibroblast activity and collagen synthesis in delicate periocular skin.
  • Targets dark circles, uneven tone and signs of fatigue by improving skin quality and radiance rather than adding bulk.
  • Helps smooth fine lines and crepiness around the eyes through enhanced hydration and extracellular matrix support.
  • Non-volumising biostimulatory profile makes it suitable for patients who want natural, refreshed results without filler-like volume.
  • Designed by UK Skin Tech Innovation/LumiPro, aligning with the LUMIFIL family of premium aesthetic injectables.
  • Single-syringe pack enables defined protocol use and predictable dosing for professional clinics.
  • Can be delivered via microneedling/mesotherapy-style techniques for minimal downtime and controlled placement.
  • Complements other aesthetic treatments (e.g. toxin, HA fillers, skin boosters) as part of a comprehensive under-eye rejuvenation strategy.

Indications

  • Under-eye dark circles associated with skin quality and microvascular changes (rather than primarily structural hollowing).
  • Fine lines, crepiness and early wrinkles in the periocular region.
  • Dull, tired-looking under-eye skin with loss of radiance and elasticity.
  • Mild under-eye laxity where improved dermal support and hydration are desired.
  • Patients seeking subtle, regenerative improvement in under-eye appearance without volumising filler.
  • Adjunctive treatment alongside other eye-area procedures in a clinic protocol, as per practitioner assessment.

Composition

  • Polydeoxyribonucleotide (PDRN) 20 mg/ml (total 30 mg per 1.5 ml syringe) – ultra-pure polynucleotides.
  • Water for injection (Aqua) as solvent.
  • Buffer salts and stabilisers (e.g. sodium salts, pH adjusters) as per manufacturer’s internal formulation (not fully disclosed on public listings).
  • No lidocaine or cross-linked hyaluronic acid is declared in publicly available composition data; LUMI-PN EYES is a PDRN solution rather than an HA filler.

Formulation

  • Sterile, clear, aqueous polynucleotide (PDRN) solution.
  • Concentration: 20 mg/ml ultra-pure PDRN (30 mg total in 1.5 ml).
  • Non-crosslinked, non-HA regenerative skin booster designed for mesotherapy/microneedling-style delivery in delicate under-eye skin.
  • Supplied as a pre-filled 1.5 ml syringe intended for single-patient professional use.

Packaging

  • Box contents: 1 × 1.5 ml pre-filled sterile syringe of LUMI-PN EYES.
  • Syringe supplied in protective blister packaging within branded outer carton.
  • Outer packaging labelled with product name, volume (1.5 ml), PDRN content (30 mg), concentration (20 mg/ml), batch/lot number, expiry date and manufacturer/supplier details.
  • Some distributors may include additional literature/leaflets; detailed Instructions for Use (IFU) are provided to professional buyers.

Usage

  • For professional use only; to be administered by qualified and appropriately trained aesthetic practitioners or healthcare professionals.
  • Indicated for the under-eye and periocular region only; avoid off-label use in areas without sufficient safety data unless supported by official guidance and local regulations.
  • Typical delivery techniques include microneedling, mesotherapy or very superficial micro-bolus/serial puncture injections into the superficial to mid-dermis around the under-eye region; deep filler-style bolus injections are not indicated.
  • Perform a full medical history, eye/skin assessment and informed consent prior to treatment; evaluate causes of dark circles (vascular, pigmentary, structural) and set appropriate expectations.
  • Cleanse and disinfect the periocular area thoroughly; use sterile gloves, needles/devices and maintain strict aseptic technique.
  • Inject/apply small amounts evenly across the treatment zone, avoiding intravascular injection and maintaining a safe distance from the eyelid margin and orbital rim, following brand and training guidelines.
  • Treatment is usually part of a course (e.g. 2–4 sessions at intervals of 2–4 weeks), according to clinic protocol and patient response; exact regimen should be tailored by the practitioner.
  • Post-treatment, advise patients to avoid touching or rubbing the area, applying makeup for at least 12–24 hours, and to avoid strenuous exercise, alcohol, saunas/steam rooms and direct sun or heat exposure for 24–48 hours.
  • Daily use of broad-spectrum SPF around the periocular area (where appropriate) should be emphasised to support and maintain results.
  • Schedule follow-up appointments to assess outcome, manage any adverse events and plan maintenance or combined treatments.

Contraindications

  • Known hypersensitivity or allergy to polynucleotides/PDRN or any excipients contained in the formulation.
  • Active infection, inflammation, dermatitis, eczema, psoriasis, open wounds or compromised skin barrier in the intended periocular treatment area.
  • History of severe allergic reactions or anaphylaxis to injectable biostimulatory products or similar treatments.
  • Autoimmune diseases, immunosuppression, uncontrolled systemic illness or coagulopathy, unless carefully assessed and cleared by a suitably qualified clinician.
  • Pregnancy and breastfeeding, as elective aesthetic injectables are generally avoided due to limited safety data.
  • Previous periocular surgery, filler or implant in the under-eye area may require additional caution and risk assessment before treatment.
  • Any other contraindications and precautions described in the official Instructions for Use or required by local professional/medical guidelines must be respected.

Adverse Effects

  • Common, usually transient effects at injection/microneedling sites: redness, mild swelling or oedema, pinpoint bleeding, tenderness, bruising and occasional pruritus.
  • Temporary papules, small bumps or grid patterns from mesotherapy injections or microneedling, which typically resolve within a few days as the product disperses.
  • Rare local inflammatory reactions, such as prolonged erythema, nodules or localised hypersensitivity.
  • Very small risk of infection if aseptic technique or aftercare instructions are not followed; may present with increasing pain, redness, warmth or discharge.
  • As with any injectable around the periocular area, inadvertent intravascular injection could theoretically lead to vascular compromise; practitioners must be trained to recognise early signs and initiate appropriate management.
  • Patients should be advised to seek immediate clinical review if they experience severe or escalating pain, visual disturbances, significant asymmetry, persistent swelling, marked discolouration or signs of infection.
  • All suspected serious adverse reactions should be documented and reported according to local pharmacovigilance and device vigilance requirements.

Storage Conditions

  • Store in original packaging in a cool, dry place away from direct sunlight and sources of heat.
  • Maintain at the temperature range specified on the pack (commonly between 2°C and 25°C); do not freeze.
  • Keep the blister and syringe sealed until use to maintain sterility.
  • Do not use if the packaging is damaged, if the syringe or solution appears compromised (e.g. discoloured, particulate matter) or if the product is past its expiry date.
  • Store out of the reach of children and unauthorised persons, in accordance with clinic storage policies for injectable aesthetic products.

Duration

As a regenerative PDRN booster, LUMI-PN EYES delivers progressive improvement rather than immediate volumetric change. Clinics typically report visible benefits after a course of 2\u20134 sessions spaced a few weeks apart, with improvements in brightness, texture and fine lines persisting for several months. Maintenance protocols (e.g. top-up sessions every 6\u201312 months) may be recommended depending on age, baseline skin quality and lifestyle; explicit duration claims are not formally stated by the manufacturer in public documents.

Onset

Patients may notice increased hydration and a subtle brightening effect within days to a few weeks after treatment. More pronounced improvements in dark circles, fine lines and overall skin quality are generally seen gradually over several weeks as collagen synthesis and tissue remodelling occur, particularly after completing a multi-session treatment course.

Browse more Injectable skin booster

Top Treatments

Top Cities in the UK